Healthequity (HQY) Return on Sales (2013 - 2026)

Healthequity's Return on Sales history runs 14 years deep, the most recent figure standing at 0.0% for Q2 2026.

• On a quarterly basis, Return on Sales changed 0.0% year-over-year to 0.0% in Q2 2026; TTM through Apr 2026 was 0.0%, a 0.0% change from a year earlier, with the FY2026 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Sales grew to 0.0% in Q2 2026 per HQY's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q2 2026 and bottomed at 0.0% in Q1 2022.
• The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.0%.
• Biggest YoY gain for Return on Sales was 0 bps in 2022; the steepest drop was 0 bps in 2022.
• Year by year, Return on Sales stood at 0.0% in 2022, then surged by 875 bps to 0.0% in 2023, then slumped by 68 bps to 0.0% in 2024, then surged by 745 bps to 0.0% in 2025, then grew by 22 bps to 0.0% in 2026.
• Per Business Quant, the three latest HQY Return on Sales figures stand at 0.0% (Q2 2026), 0.0% (Q1 2026), and 0.0% (Q4 2025).